Avanzati Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 01-01-2025
- Paid Up Capital ₹ 0.20 M
as on 01-01-2025
- Company Age 3 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 162.31%
(FY 2023)
- Profit -95.79%
(FY 2023)
- Ebitda -111.41%
(FY 2023)
- Net Worth -9317.10%
(FY 2023)
- Total Assets -23.36%
(FY 2023)
About Avanzati Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Ghadge Jaynath, Balchand Bhandari, Taruna Rathod, and One other member serve as directors at the Company.
- CIN/LLPIN
U74999MH2021PTC364687
- Company No.
364687
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Jul 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Avanzati Pharma?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ghadge Jaynath  | Director | 14-Dec-2024 | Current |
| Balchand Bhandari | Director | 14-Dec-2024 | Current |
| Taruna Rathod | Director | 27-Jul-2021 | Current |
| Aaryesh Rathod | Director | 27-Jul-2021 | Current |
Financial Performance of Avanzati Pharma.
Avanzati Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 162.31% increase. The company also saw a substantial fall in profitability, with a 95.79% decrease in profit. The company's net worth observed a substantial decline by a decrease of 9317.1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Avanzati Pharma?
Unlock access to Avanzati Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Avanzati Pharma?
Avanzati Pharma has a workforce of 0 employees as of Mar 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Avanzati Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Avanzati Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
